Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Jaen

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pharmaceutical Research|August 1, 1991
Synthesis of the enantiomers of reduced haloperidolJ C Jaen, B W Caprathe, S Priebe, et al.
Critical Reviews in Neurobiology|January 1, 1993
Therapeutic intervention in dementiaR E Davis, M R Emmerling, J C Jaen, et al.
Journal of Medicinal Chemistry|November 26, 1993
Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptorsJ C Jaen, B W Caprathe, T A Pugsley, et al.
Journal of Medicinal Chemistry|August 1, 1988
Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilinesJ C Jaen, L D Wise, T G Heffner, et al.
Journal of Medicinal Chemistry|January 1, 1991
Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-onesJ C Jaen, L D Wise, T G Heffner, et al.
The Journal of Biological Chemistry|July 31, 1999
Secreted site-1 protease cleaves peptides corresponding to luminal loop of sterol regulatory element-binding proteinsD Cheng, P J Espenshade, C A Slaughter, et al.
Life Sciences|January 1, 1993
Characterization of muscarinic agonists in recombinant cell linesR D Schwarz, R E Davis, J C Jaen, et al.
Mutation Research|April 1, 1992
Chemical purity and mutagenicity: case study of a drug in developmentM L Kropko, J C Jaen, J C Theiss, et al.
Life Sciences|January 1, 1995
Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonistsR D Schwarz, C J Spencer, J C Jaen, et al.
Journal of Medicinal Chemistry|July 19, 1996
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacologyW F Pool, T F Woolf, M D Reily, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|August 1, 1991
Synthesis of the enantiomers of reduced haloperidolJ C Jaen, B W Caprathe, S Priebe, et al.
Critical Reviews in Neurobiology|January 1, 1993
Therapeutic intervention in dementiaR E Davis, M R Emmerling, J C Jaen, et al.
Journal of Medicinal Chemistry|November 26, 1993
Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptorsJ C Jaen, B W Caprathe, T A Pugsley, et al.
Journal of Medicinal Chemistry|August 1, 1988
Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilinesJ C Jaen, L D Wise, T G Heffner, et al.
Journal of Medicinal Chemistry|January 1, 1991
Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-onesJ C Jaen, L D Wise, T G Heffner, et al.
The Journal of Biological Chemistry|July 31, 1999
Secreted site-1 protease cleaves peptides corresponding to luminal loop of sterol regulatory element-binding proteinsD Cheng, P J Espenshade, C A Slaughter, et al.
Life Sciences|January 1, 1993
Characterization of muscarinic agonists in recombinant cell linesR D Schwarz, R E Davis, J C Jaen, et al.
Mutation Research|April 1, 1992
Chemical purity and mutagenicity: case study of a drug in developmentM L Kropko, J C Jaen, J C Theiss, et al.
Life Sciences|January 1, 1995
Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonistsR D Schwarz, C J Spencer, J C Jaen, et al.
Journal of Medicinal Chemistry|July 19, 1996
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacologyW F Pool, T F Woolf, M D Reily, et al.
Pageof 3